Chicago Rivet & Machine (CVR) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
24 Mar, 2026Executive summary
Reported a net loss of $1.08 million for 2025, a significant improvement from a $5.62 million net loss in 2024, despite only a modest 3% increase in net sales year-over-year.
Substantial doubt remains about the ability to continue as a going concern due to recurring operating losses, negative cash flows, and reduced liquidity.
Strategic actions underway include asset sales, renewed credit facilities, and operational efficiency improvements.
Financial highlights
Net sales for 2025 were $27.89 million, up 3% from $26.99 million in 2024.
Gross profit rose to $4.13 million from $1.06 million year-over-year, driven by operational efficiencies and improved pricing.
Operating loss narrowed to $1.20 million from $5.16 million in 2024.
Cash and equivalents at year-end were $1.72 million, down from $1.92 million.
Dividends paid totaled $0.12 per share in 2025.
Outlook and guidance
Order volume improved in Q1 2026 versus Q4 2025, but remains below historic levels.
Continued focus on cost reduction, efficiency, and new sales opportunities to drive volume recovery.
Ongoing monitoring of tariffs, market, and geopolitical risks expected to impact 2026 performance.
Latest events from Chicago Rivet & Machine
- Shareholders will vote on director elections, executive pay, auditor ratification, and governance matters.CVR
Proxy Filing2 Dec 2025 - Returned to profitability in Q3 2025, but going concern risks persist amid industry challenges.CVR
Q3 20257 Nov 2025 - Q2 2024 returned to profit on improved margins, despite flat sales and ongoing risk from a product issue.CVR
Q2 202429 Sep 2025 - Sales fell 12.3% YoY in Q3 2024, with improved margins but a net loss of $1.45M.CVR
Q3 202429 Sep 2025 - Significant 2024 losses, liquidity risks, and operational restructuring amid industry headwinds.CVR
Q4 202429 Sep 2025 - Gross margin and net income improved despite lower sales, but liquidity risks persist.CVR
Q1 202529 Sep 2025 - Sales and margins declined in Q2 2025, raising going concern doubts despite cost actions.CVR
Q2 202529 Sep 2025